Infectious Diseases Society of America Launches Call for Applications for Next Editor-in-Chief of Clinical Infectious Diseases
The Infectious Diseases Society of America seeks candidates to serve in the position of editor-in-chief of Clinical Infectious Diseases. The term of the current editor-in-chief, Robert T. Schooley, MD, FIDSA, is ending in mid-2022, after years of distinguished service to the journal and the Society.
Published continuously since 1979, CID is a leading journal in the field of infectious diseases with a broad international readership. The journal publishes articles on a variety of subjects of interest to practitioners and researchers. Topics range from clinical descriptions of infections, HIV/AIDS, public health, microbiology and immunology to the prevention of infection, the evaluation of current and novel treatments and the promotion of optimal practices for diagnosis and treatment.
IDSA is seeking a physician scientist with a record of academic excellence in clinical research and wide and inclusive knowledge of the field of infectious diseases to guide CID’s advancement over the next 5–10 years. The successful applicant will demonstrate a compelling strategic vision for the journal’s ongoing development and differentiation from the Society’s other two journals, The Journal of Infectious Diseases and Open Forum Infectious Diseases, and other reputable journals in the field; a profound commitment to diversity, inclusion, access and equity; excellent communication skills and an outstanding reputation for professionalism and collegiality; a collaborative leadership style; a clear understanding of trends in scientific journal publishing, including optimizing digital functionality and the deployment of social media channels; an international network of colleagues; and prior editorial experience.
Candidates should also have deep understanding of the challenges faced by the field of infectious diseases with a passion to build awareness and improve its visibility, expertise in current scientific methodology and strong understanding of clinical research and clinical trials design and implementation. See the complete editor-in-chief position description for further detail.
Interested candidates should submit the following via email to the Chair, CID Editor-in-Chief Search Committee, c/o Lisa Junker, IDSA senior director of publishing & content strategy, email@example.com:
- Full CV;
- A letter (maximum 2 pages) summarizing your vision and goals for CID over the next 5 years, with attention to how you would like to innovate and build on CID’s success and to how you will promote diversity, inclusion, access and equity within the journal and the broader infectious diseases community;
- A letter of support from your institution (approximately 50% release time; all editorial management and administrative support will be provided by IDSA);
- Two letters of recommendation from your peers that address your research, medical writing and editorial abilities, as well as your professionalism and collegiality in the workplace and in editorial activities.
The deadline for applications is Oct. 18, 2021.
For questions about the editor-in-chief position or application process, please contact Lisa Junker at firstname.lastname@example.org.
About the Infectious Diseases Society of America:
IDSA is a leader on issues of importance to ID professionals, including education and training, policy and advocacy, setting guidelines for patient care, and developing resources for clinical practice. It remains at the forefront of global health issues such as antimicrobial resistance and HIV/AIDS. Housed within IDSA is the HIV Medicine Association (HIVMA), which represents medical providers and researchers working on the front lines of HIV. More than 12,000 IDSA and HIVMA members work across the United States and in nearly 100 other countries on six different continents. For more information visit www.idsociety.org. Follow IDSA on Facebook and Twitter.